[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-350544-en":59,"doc-seo-350544-105":98},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":72,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":31,"preview_page_count":19,"preview_urls":80},350544,2336478940917,"Aldword","https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Therapeutic Potential of Ziyuglycosides from Sanguisorba officinalis - Anticancer and Immunomodulatory Properties","Cancer represents a major global health threat, requiring effective anticancer therapies. Sanguisorba officinalis (DY), a traditional Chinese herbal medicine, includes blood-cooling and blood-circulation promotion, detoxification, and wound-astringency activities. Evidence indicates DY and its bioactive ziyuglycosides exert anti-tumor effects, yet systematic reviews remain limited. This review summarizes anticancer and immunomodulatory mechanisms: DY extracts and ziyuglycosides regulate Wnt/β-catenin, PI3K/AKT/mTOR, MAPK, and EGFR/NF-κB, suppress invasion and metastasis, and modulate the tumor immune microenvironment, Th17/Treg balance, and CD8+ responses, supporting translational research for cancer therapy.","Drug Design, Development and Therapy  \n Open Access Full Text Article  \nREVIEW  \nTherapeutic Potential of Ziyuglycosides from Sanguisorba officinalis: Anticancer and Immunomodulatory Properties  \nJiaying Qi 1 , 2 , *, Ying Zhong2 , 3 , *, Nana Huang2–4 , Hang Du2 , 3 , Jianchao Li 5 , Xiaolu Li2 , 3 , Rong Sun 1–4  \n1School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China; 2Integrated Traditional Chinese and Western Medicine Center, The Second Qilu Hospital of Shandong University, Jinan, People’s Republic of China; 3National Administration of Traditional Chinese Medicine, High-Level Key Disciplines of Traditional Chinese Medicine, Toxicology of Traditional Chinese Medicine, Shandong University, Jinan, People’s Republic of China; 4Advanced Medical Research Institute, Shandong University, Jinan, People’s Republic of China; 5School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Rong Sun, School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, 10 Poyanghu Road, Tianjin, 301617, People’s Republic of China, Tel/Fax +86 13605311799, Email [sunrong@sdu.edu.cn](sunrong@sdu.edu.cn)  \n\n| Abstract: Cancer represents a major global health threat, and the development of effective anticancer therapies is urgently needed. Sanguisorba officinalis (DY), a traditional Chinese herbal medicine, possesses properties including cooling blood and promoting blood circulation, detoxifying pathogenic toxins, and astringing sores. Increasing evidence suggests that DY and its bioactive constituents exhibit notable anti-tumor effects, with mechanisms that align with traditional Chinese medical principles of enhancing Zhengqi (fuzheng) and removing Xieqi (quxie) . However, a comprehensive review that systematically summarizes the antitumor potential of DY and its bioactive constituents is still lacking. In this review, we summarize the anticancer effects of DY extracts and Ziyuglycosides. In vitro studies demonstrate that DY and its active components can inhibit tumor cell proliferation, induce cell cycle arrest, trigger mitochondria-mediated apoptosis, enhance autophagic flux, and suppress invasion and metastasis by regulating Wnt/β-catenin, PI3K/AKT/mTOR, MAPK, and EGFR/NF-κB signaling pathways, as well as downregulating epithelial-mesenchymal transition-related transcription factors and matrix metalloproteinases. In vivo studies confirms DY and its active components inhibit tumor growth and metastasis, regulate the tumor immune microenvironment, modulate Th17/Treg balance, activate CD8+ T cells, and enhance the anti-tumor immune responses. Notably, clinical application evidence indicates that Diyu Shengbai Pian, a preparation derived from DY, have been proven effective in alleviating leukopenia caused by chemotherapy or radiotherapy, highlighting DY’s dual therapeutic potential in tumor suppression and mitigating treatment-related adverse reactions. However, current research mainly focuses on in vitro cellular studies and in vivo animal models, lacking large-scale, standardized clinical trials to validate its long-term efficacy and safety in humans. This review systematically summarizes the mechanisms of the anti-tumor and immunomodulatory effects of DY and its active components, and outlines advancements in improving their in vivo delivery efficiency, providing a theoretical basis and research reference for the translational application of DY in cancer therapy.\u003Cbr>Keywords: Sanguisorba officinalis, ziyuglycoside I, ziyuglycoside II, anticancer, immunomodulatory |\n| --- |\n| Introduction\u003Cbr>Cancer remains a significant challenge to global public health, with high incidence and mortality rates posing a persistent threat to human health. According to GLOBOCAN 2022, approximately 20 million new cancer cases and 9.7 million deaths occurred worldwi","cbCaic2E8QohthEW","https://ap.wps.com/l/cbCaic2E8QohthEW","pdf",7253903,11,"English","en",105,"# Abstract\n# Introduction","[{\"question\":\"What anticancer effects do DY extracts and ziyuglycosides show in vitro and in vivo?\",\"answer\":\"In vitro, DY and its components inhibit proliferation, induce cell cycle arrest and mitochondria-mediated apoptosis, enhance autophagic flux, and suppress invasion and metastasis. In vivo, they inhibit tumor growth and metastasis and influence the tumor immune microenvironment.\"},{\"question\":\"Which signaling pathways are highlighted for DY’s anti-tumor mechanisms?\",\"answer\":\"The review emphasizes regulation of Wnt/β-catenin, PI3K/AKT/mTOR, MAPK, and EGFR/NF-κB pathways, alongside downregulation of EMT-related transcription factors and matrix metalloproteinases.\"},{\"question\":\"What immunomodulatory effects are described in the tumor immune microenvironment?\",\"answer\":\"DY and its active components regulate Th17/Treg balance, activate CD8+ T cells, and enhance anti-tumor immune responses in vivo.\"}]","Therapeutic Potential of Ziyuglycosides from Sanguisorba officinalis - Anticancer and Immunomodulatory Properties | PDF",1790089511,[81,85,89,94],{"page_no":8,"url":82,"width":83,"height":84},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4efce3a1a1b81c05f9daff6aedf2971.webp",983,1272,{"page_no":14,"url":86,"width":87,"height":88},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9599c9d4899ed21ad94c2355b797b552.webp",982,1270,{"page_no":90,"url":91,"width":92,"height":93},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/673c179f048882f6de7abd2ab73083c9.webp",981,1269,{"page_no":19,"url":95,"width":96,"height":97},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a4243026fa547ffb05c74c3a5b8a1bb.webp",980,1268,{"code":4,"msg":99,"data":100},"ok",{"site_id":75,"language":74,"slug":101,"title":65,"keywords":102,"description":66,"schema_data":103,"social_meta":156,"head_meta":158,"extra_data":160,"updated_unix":161},"therapeutic-potential-of-ziyuglycosides-from-sanguisorba-officinalis-anticancer-and-immunomodulatory-properties","",{"@graph":104,"@context":155},[105,118,138],{"@type":106,"itemListElement":107},"BreadcrumbList",[108,112,114,116],{"item":109,"name":110,"@type":111,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":113,"name":9,"@type":111,"position":14},"https://docshare.wps.com/document/",{"item":115,"name":40,"@type":111,"position":90},"https://docshare.wps.com/document/research-report/",{"item":117,"name":65,"@type":111,"position":19},"https://docshare.wps.com/document/therapeutic-potential-of-ziyuglycosides-from-sanguisorba-officinalis-anticancer-and-immunomodulatory-properties/350544/",{"url":117,"name":65,"@type":119,"image":120,"author":125,"headline":65,"publisher":127,"fileFormat":130,"inLanguage":74,"description":66,"dateModified":131,"datePublished":132,"encodingFormat":130,"isAccessibleForFree":133,"interactionStatistic":134},"DigitalDocument",{"url":121,"@type":122,"width":123,"height":124},"https://docshare.wps.com/thumbnails/therapeutic-potential-of-ziyuglycosides-from-sanguisorba-officinalis-anticancer-and-immunomodulatory-properties/350544.png","ImageObject",300,407,{"name":63,"@type":126},"Person",{"url":109,"name":128,"@type":129},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":135,"interactionType":136,"userInteractionCount":72},"InteractionCounter",{"@type":137},"ViewAction",{"@type":139,"mainEntity":140},"FAQPage",[141,147,151],{"name":142,"@type":143,"acceptedAnswer":144},"What anticancer effects do DY extracts and ziyuglycosides show in vitro and in vivo?","Question",{"text":145,"@type":146},"In vitro, DY and its components inhibit proliferation, induce cell cycle arrest and mitochondria-mediated apoptosis, enhance autophagic flux, and suppress invasion and metastasis. In vivo, they inhibit tumor growth and metastasis and influence the tumor immune microenvironment.","Answer",{"name":148,"@type":143,"acceptedAnswer":149},"Which signaling pathways are highlighted for DY’s anti-tumor mechanisms?",{"text":150,"@type":146},"The review emphasizes regulation of Wnt/β-catenin, PI3K/AKT/mTOR, MAPK, and EGFR/NF-κB pathways, alongside downregulation of EMT-related transcription factors and matrix metalloproteinases.",{"name":152,"@type":143,"acceptedAnswer":153},"What immunomodulatory effects are described in the tumor immune microenvironment?",{"text":154,"@type":146},"DY and its active components regulate Th17/Treg balance, activate CD8+ T cells, and enhance anti-tumor immune responses in vivo.","https://schema.org",{"og:url":117,"og:type":157,"og:title":65,"og:site_name":128,"og:description":66},"article",{"robots":159,"canonical":117},"index,follow",{"doc_id":61,"site_id":75},1790929646]